PJP Pneumonia — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Pneumocystis jirovecii pneumonia – IV trimethoprim-sulfamethoxazole plus prednisolone
PJP (Pneumocystis jirovecii pneumonia) presents in severely immunosuppressed HIV patients (CD4 <200) with subacute dyspnoea, dry cough, bilateral perihilar infiltrates, elevated LDH, and hypoxia. First-line treatment is IV TMP-SMX (15–20 mg/kg/day of TMP component) for 21 days. Adjunctive prednisolone is indicated when PaO₂ <70 mmHg (or A-a gradient >35 mmHg), as it reduces mortality (Bozzette trial). ART should be commenced within 2 weeks.
Reference: eTG – 2025 – Antibiotic Guidelines; ASHM – 2024 – HIV Management Guidelines